Aelin Therapeutics

📍 Leuven, Belgium🗓 Founded 2017👥 39 employees💰 Last funded 2018
Biotechnology Research🌐 aelintx.com
Website LinkedIn
Aelin Therapeutics is a privately held Belgian biotechnology company, pioneering a novel modality in drug development. Using our Pept-in platform technology, we can create a completely new class of antibiotics and first-in-class therapeutics against high-value undruggable human targets. The technology harnesses the power of protein aggregation to specifically induce functional knockdown of a target protein.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
Belgium
1
Frequently asked questions
Who invested in Aelin Therapeutics?
Aelin Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Aelin Therapeutics last raise funding?
The most recent investment in Aelin Therapeutics recorded on gritt.io was in 2018.
When was Aelin Therapeutics founded?
Aelin Therapeutics was founded in 2017.
What industry is Aelin Therapeutics in?
Aelin Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aelin Therapeutics based?
Aelin Therapeutics is headquartered in Leuven, Belgium.